H20 Venture Partners

H2O Venture Partners is an Oxford-based venture capital firm specializing in building high-impact, scalable enterprises from scratch. Their unique approach focuses on sectors like agriculture, health, and environmental technologies, particularly in underserved markets. Notable portfolio companies include Oxitec, known for its genetic pest control solutions, and Fuel3D, a spinout using advanced 3D imaging in healthcare. The firm’s Chariot Fund emphasizes telemedicine and point-of-care technologies, aiming to revolutionize healthcare in developing regions such as India, where these innovations are rapidly adopted. H2O’s strategy is distinct in its "build-from-scratch" model, which involves creating businesses to fill gaps in value chains where no established companies exist. Their investments often target early-stage companies, where they guide ventures through pilot phases into scalable, long-term businesses. The firm is active in East Africa, with a notable presence in Rwanda and Tanzania, in addition to their UK operations. Led by David Kelly and Paul Coleman, H2O places a strong emphasis on commercial discipline and social impact, seeking companies with the potential for both profitability and substantial social benefits. They prefer businesses that are mission-driven, focusing on transforming sectors like smallholder farming and telemedicine. Their hands-on, phased approach to growth helps minimize risk while scaling operations.